Zhengye Biotechnology Holding Limited (ZYBT) Comparison with companies in other sectors?

Zhengye Biotechnology Holding Limited has a share price of 47.39M. You can analyze Zhengye Biotechnology Holding Limited (ZYBT) competitors across different market sectors through stock heatmaps.

What are ZYBT's NET and operating margins?

Zhengye Biotechnology Holding Limited (ZYBT) operating margin is around 0.21, and net profit margin is approximately 0.15 as of the latest reports.

In what way does ZYBT's earnings per share (EPS) trend reflect its financial momentum?

Zhengye Biotechnology Holding Limited (ZYBT) EPS is 0.03 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Zhengye Biotechnology Holding Limited is 185.00, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Zhengye Biotechnology Holding Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Zhengye Biotechnology Holding Limited like P/E which is 0.00, P/B which is 0.00, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Zhengye Biotechnology Holding Limited

ZYBT•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$5.55

$0.00(0.00%)

Fundamental Analysis of Zhengye Biotechnology Holding Limited (ZYBT)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.03

P/E Ratio

185.00

ROE

0.11%

Net Margin

0.15%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$263.02M

Shares OutstandingTotal number of shares issued

$47.39M

Book Value/ShareNet worth per share

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.03

Net MarginNet income as percentage of revenue

14.86%

Operating MarginOperating income as percentage of revenue

21.25%

ROEReturn on shareholders' equity

11.05%

ROAReturn on total assets

6.29%

ROCEReturn on capital employed

12.87%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

1.98%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for ZYBTFinancial Ratios Analysis details for ZYBT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ZYBTSector Benchmarking details for ZYBT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Zhengye Biotechnology Holding Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Zhengye Biotechnology Holding Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Zhengye Biotechnology Holding Limited's unique business strengths and challenges.

Key Financial Metrics for Zhengye Biotechnology Holding Limited

For Zhengye Biotechnology Holding Limited, essential financial indicators include EPS 0.03, PE 185.00, and ROE 0.11. These key ratios reveal insights into Zhengye Biotechnology Holding Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Zhengye Biotechnology Holding Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Zhengye Biotechnology Holding Limited

Metrics like Net Margin 14.86% and ROA 6.29% shed light on how well Zhengye Biotechnology Holding Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Zhengye Biotechnology Holding Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Zhengye Biotechnology Holding Limited

Using ratios such as P/B Ratio - and PEG Ratio -, investors can assess whether Zhengye Biotechnology Holding Limited is appropriately valued based on its financials and growth potential. These figures, combined with Zhengye Biotechnology Holding Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Zhengye Biotechnology Holding Limited

Financial health indicators, such as Debt/Equity Ratio 0.33 and Cash Flow -, provide a snapshot of Zhengye Biotechnology Holding Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Zhengye Biotechnology Holding Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Zhengye Biotechnology Holding Limited

Investing in Zhengye Biotechnology Holding Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Zhengye Biotechnology Holding Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;